BDBM451763 6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)-3,4-dihydroisoquinolin- 1(2H)-one::US10710978, Compound I-76

SMILES Nc1ncc(cc1-c1ccc2C(=O)NCCc2c1)-c1scnc1Cl

InChI Key InChIKey=VQVBIURGGWKQOR-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 451763   

TargetSerine/threonine-protein kinase 4(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451763(6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...)
Affinity DataIC50: <40nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase 3(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451763(6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...)
Affinity DataIC50:  120nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase 24(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451763(6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...)
Affinity DataIC50: >900nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase 26(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451763(6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...)
Affinity DataIC50: >1.00E+3nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase 4(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451763(6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...)
Affinity DataIC50:  120nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase 3(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451763(6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...)
Affinity DataIC50: >1.00E+3nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase 24(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451763(6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...)
Affinity DataIC50: >1.00E+3nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase 26(Homo sapiens (Human))
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM451763(6-(2-amino-5-(4- chlorothiazol-5-yl)pyridin-3- yl)...)
Affinity DataIC50: >1.00E+3nMAssay Description:Biochemical IC50s were measured at Invitrogen using Z-lyte technology. Briefly, for STK4, the 2×STK4 (MST1)/Ser/Thr 07 mixture was prepared in 50 mM ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent